Vertex Pharmaceuticals Market Sentiment

Vertex Pharmaceuticals Inc

VRTXNASDAQ

Trade with Public

$556.75

9.101.66%

In chiusura: Sep 2, 5:00 PM EST

$557.00

0.250.04%

Post-mercato: 7:27 PM EST

Fusioni e acquisizioni: Crinetics Pharmaceuticals (CRNX) was acquired by Vertex Pharmaceuticals (VRTX) on Tuesday, September 1, 2026 for $10B paid in cash

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Opzioni Rapporto azionario

Vertex Pharmaceuticals Market Sentiment

Market sentiment signals for Vertex Pharmaceuticals (VRTX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 1.9% short float

Options Flow▼ 1.34 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

33 analysts

Options Flow (P/C)

1.34

More puts — Bearish

1,097 calls · 1,467 puts

Avg Consensus PT

$542

-2.8%

Highest Price Target

$665

+19.4%

Morgan Stanley

Lowest Price Target

$350

-37.2%

Baird

Short Interest

1.9%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 2, 2026	Morgan Stanley	Terence Flynn—	+19.4%	$665	Reinstates	Overweight
Aug 5, 2026	Truist Securities	Danielle Brill—	+1.4%	$560 → $565	Maintained	Buy
Aug 5, 2026	Barclays	Eliana Merle—	+10.8%	$615 → $617	Maintained	Overweight
Aug 4, 2026	TD Cowen	Phil Nadeau—	-1.3%	$525 → $550	Maintained	Buy
Aug 4, 2026	Cantor Fitzgerald	Carter Gould—	+6.8%	$590 → $595	Maintained	Overweight
Aug 4, 2026	Canaccord Genuity	Whitney Ijem—	-20.6%	$436 → $442	Maintained	Hold
Jul 13, 2026	UBS	Michael Yee—	+5.0%	$545 → $585	Maintained	Buy
Jul 13, 2026	Truist Securities	Danielle Brill—	+0.5%	$542 → $560	Maintained	Buy
Jul 7, 2026	RBC Capital	Brian Abrahams—	+2.3%	$543 → $570	Maintained	Outperform
Jul 7, 2026	Baird	Brian Skorney—	-37.2%	$330 → $350	Maintained	Underperform
May 6, 2026	Barclays	Eliana Merle—	+10.4%	$607 → $615	Maintained	Overweight
May 5, 2026	Canaccord Genuity	Whitney Ijem—	-21.7%	$437 → $436	Maintained	Hold
May 5, 2026	Morgan Stanley	Terence Flynn—	+10.6%	$612 → $616	Maintained	Overweight
May 5, 2026	Bernstein	William Pickering—	+2.7%	$577 → $572	Maintained	Outperform
May 5, 2026	RBC Capital	Brian Abrahams—	-2.5%	$541 → $543	Maintained	Outperform
Apr 30, 2026	Canaccord Genuity	Whitney Ijem—	-21.5%	$441 → $437	Maintained	Hold
Apr 10, 2026	Morgan Stanley	Terence Flynn—	+9.9%	$596 → $612	Maintained	Overweight
Mar 18, 2026	Maxim Group	Naz Rahman—	+3.2%	$575	Upgrade	Hold→Buy
Mar 11, 2026	Truist Securities	Joon Lee—	-5.7%	$490 → $525	Maintained	Buy
Mar 10, 2026	Morgan Stanley	Terence Flynn—	+7.0%	$570 → $596	Maintained	Overweight
Mar 10, 2026	B of A Securities	Ying Huang—	+7.4%	$571 → $598	Maintained	Buy
Mar 10, 2026	Citigroup	Geoff Meacham—	+5.0%	$575 → $585	Maintained	Buy
Mar 10, 2026	Oppenheimer	Jay Olson—	+7.7%	$540 → $600	Maintained	Outperform
Mar 10, 2026	Jefferies	Akash Tewari—	+4.1%	$580	Initiate	Buy
Mar 10, 2026	HC Wainwright & Co.	Andrew S. Fein—	+15.1%	$591 → $641	Maintained	Buy